We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Bruker Announces Agreement To Acquire Neurescence Inc., Bolstering Neuroscience Research Portfolio

The Bruker logo and neurescence logo

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Bruker Announces Agreement To Acquire Neurescence Inc., Bolstering Neuroscience Research Portfolio"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Bruker Corporation (Nasdaq: BRKR) has announced the signing of the definitive agreement to purchase 100% of the shares of Neurescence Inc., an innovative provider of ultralight fiber-bundle MultiscopesTM for simultaneous multi-region, optical functional neuroimaging. Neurescence’s flagship product Chromatone™ moves illumination and detection hardware off the animal head. This enables simultaneous imaging and stimulation of three sub-types of neurons in up to four regions for flexible investigation of the central nervous system with single-neuron resolution in naturalistic behavior. This platform creates strong synergies with Bruker’s existing Ultima multiphoton solutions and newly acquired Inscopix head-mounted miniscopes. Financial details of the agreement were not disclosed.


“Our differentiated system provides a viable means of performing multi-region-of-interest investigation with minimal weight impact to subject animals,” said Dr. Yasaman Soudagar, Co-Founder and CEO of Neurescence. “Now, with Bruker, we can greatly increase the worldwide reach of this technology to enable researchers to gain deeper knowledge of neural network functions.”


“Along with our recent addition of Inscopix, this acquisition bolsters Bruker’s position as the leading provider of freely behaving animal imaging and photostimulation,” added Dr. Mark R. Munch, Bruker NANO Group President. “Neurescence’s extremely flexible and light-weight fiber-bundle MultiscopeTM with off-animal approach has great potential to address diversified research needs and future trends, opening the door to advanced imaging modalities.”

Advertisement